NCT01377922 2018-01-04A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)Catalyst Pharmaceuticals, Inc.Phase 3 Completed38 enrolled 12 charts
NCT00004832 2015-03-25Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic SyndromeFDA Office of Orphan Products DevelopmentPhase NA Completed26 enrolled